CHICAGO & CAMBRIDGE, Mass.--Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, announced that it will host a virtual R&D Day on Thursday, January 7th, 2021 from 09:00 am to 10:30 am ET to discuss Exicure’s neuroscience pipeline, including its lead… Read More..

Supports CoVaccine HT™ platform development PRINCETON, N.J., Dec. 28, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part… Read More..

CPS is Expected to Generate Approximately $20 Million In Revenue and $1 Million of EBITDA in 2020 Acquisition Includes Approximately $5.2 Million in Estimated Working Capital and is Debt Free LiveXLive Plans to Partner with Artists and Talent to Exclusively Own and Distribute Unique Proprietary Products to be Marketed During… Read More..